Programmable DNA-augmented hydrogels for controlled activation of human lymphocytes

Alexander S Zhovmer1, Morgan Chandler2, Alexis Manning1

  • 1Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.

Summary

Researchers developed a new nucleic acid nanoassembly (NAN) technology to study mechanical forces on T cell receptors (TCRs) during immune surveillance. This platform enables tunable TCR activation, offering insights into early immune responses.

Related Concept Videos